tirzepatide use in pregnancy of GLP-1 drugs early should not cause alarm, analysis suggests Tirzepatide and Pregnancy Planning |

YX: Conceptualization, Data curation, Investigation, Methodology, Writing - original draft

For a common 5 mg/mL compounded vial on a U-100 syringe: 5 units for 0.25 mg, 10 units for 0.5 mg, 20 units for 1.0 mg, 34 units for 1.7 mg, and 48 units for 2.4 mg

They are commonly administered once or twice per week, depending on the protocol and patient response

Patients with diabetic gastroparesis or severe gastroesophageal reflux disease may experience exacerbation of symptoms with higher doses due to delayed gastric emptying

-For those with symptoms, alternatives like liquid diets or specific intubation techniques are suggested